330
Participants
Start Date
November 4, 2010
Primary Completion Date
May 7, 2012
Study Completion Date
May 7, 2012
Aeroquin
Inhalation Solution
Placebo
Inhalation Solution
New York
New York
New York
Valhalla
Albany
Syracuse
Pittsburgh
Hershey
Philadelphia
Philadelphia
Wilmington
Charlottesville
Richmond
Norfolk
Portsmouth
Morgantown
Chapel Hill
Columbia
Charleston
Atlanta
Rambam Medical Center, Haifa
Jacksonville
Orlando
Miami
Tampa
St. Petersburg
Mobile
Nashville
Memphis
Jackson
Louisville
Lexington
Columbus
Toledo
Akron
Cincinnati
Dayton
Indianapolis
Ann Arbor
Detroit
Schneider Childrens Medical Center of Israel, Petah Tikva
Grand Rapids
Sheba Medical Center, Ramat Gan
Milwaukee
Minneapolis
Sioux Falls
Glenview
Chicago
Chicago
Niles
St Louis
St Louis
Kansas City
Columbia
Wichita
Omaha
New Orleans
Oklahoma City
Oklahoma City
Dallas
Tyler
Fort Worth
Houston
San Antonio
Austin
Aurora
Denver
Boise
Salt Lake City
Phoenix
Tucson
Albuquerque
Las Vegas
Childrens Hospital, Los Angeles
Los Angeles
Long Beach
Hadassah Medical Center Mount Scopus, Jerusalem
La Jolla
San Diego
Orange
San Francisco
San Francisco
Palo Alto
Oakland
Sacramento
Seattle
Seattle
Anchorage
Hartford
Portland
Boston
Boston
Worcester
Lebanon
Manchester
Livingston
Long Branch
Morristown
Colchester
John Hunter Hospital, New South Wales
Westmead Chilren's Hospital, Westmead
Westmead Hospital, Westmead
Mater Miscericordiae Hospital, Brisbane
Brisbane
Royal Adelaide Hospital, Adelaide
Royal Children's Hospital, Melbourne
The Alfred Hospital, Melbourne
Monash Medical Center, Melbourne
Auckland Hospital, Auckland
Hamilton
Kingston
Ottawa
Lead Sponsor
Collaborators (1)
Forest Laboratories
INDUSTRY
Amgen
INDUSTRY